Development

Feliza Mirasol is the science editor for 

Articles

MediWound has been granted an additional $6.7 million by the DoD to advance NexoBrid as a non-surgical field care solution for the US military.

DoD Grants Additional Funds to MediWound for Advancement of Non-Surgical Treatment for Field Care Burns

The draft guidance document discusses quality considerations for topical ophthalmic drug products.

FDA Issues Guidance for Topical Ophthalmic Drugs

Lei Lei is senior R&D director of Cutia Therapeutics, Shanghai, China, and he was principal scientist of Shanghai Johnson & Johnson Pharmaceutical Company

FDA’s new guidance on in-vitro permeation test studies published in October 2022 gives technical and statistical requirements for conducting these tests to compare topical generic drugs with their reference products.

In-Vitro Permeation Test Data Analysis with MS Excel as per FDA’s Guidance

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.

Aiming for Improved Efficacy and Patient Compliance for Topical Ophthalmics

Gerresheimer has developed a new dropper insert for ophthalmic formulations that it is showcasing at CPHI 2022 in Frankfurt, Germany.

Gerresheimer Showcases DropControl, a New Dropper Solution for Ophthalmic Formulations, at CPHI 2022

API permeation into the skin modulates the efficacy of topical treatments.

Delivery Kinetics for Topical Drugs

Suzanne Shelley is contibuting editor to 

Ongoing advances in technology and modeling techniques are helping to align all the objectives of both drug manufacturers and patients.

Topical Formulations in Pharma–Balancing Form and Function

MedPharm’s new facility for process development and small-scale manufacturing is in North Carolina, near its existing R&D center.

MedPharm Opens Manufacturing Facility for Topical and Transdermal Drug Products

Supriya Bhide is a graduate student at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

Apoorva Panda is a graduate student at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

S. Rangappa is a research scientist at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

Abhishek Shettar is a research scientist at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

M.A. Repka is professor and chair at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

Rosa Maria Badani Prado is a graduate student at the Dave C. Swalm School of Chemical Engineering, Mississippi State University, MS.

S. Kundu is associate professor at the Dave C. Swalm School of Chemical Engineering, Mississippi State University, MS.

Norman Richardson is technical sales manager at BASF Pharma Solutions, Florham Park, NJ.

S. Narasimha Murthy is professor of Pharmaceutics and Drug Delivery at the University of Mississippi, MS, founder-director of the Institute for Drug Delivery and Biomedical Research, Bangalore, Karnataka, India, and chief scientific officer, Topical Products Testing LLC, University, MS.

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.

Formulation and Drug Delivery, Topical Drugs